Computational Medicine and Drug Discovery Software Market, Global Outlook and Forecast 2023-2030
Computational Medicine finds its roots in chemistry and quantum mechanics. The foundation of computational medicine is based upon database and constraint-based models.
This report aims to provide a comprehensive presentation of the global market for Computational Medicine and Drug Discovery Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Medicine and Drug Discovery Software. This report contains market size and forecasts of Computational Medicine and Drug Discovery Software in global, including the following market information:
Global Computational Medicine and Drug Discovery Software Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Computational Medicine and Drug Discovery Software market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The computational medicine and drug discovery market is poised to grow at a CAGR of 5.1% to reach $6.78 Billion by 2020.
We surveyed the Computational Medicine and Drug Discovery Software companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Computational Medicine and Drug Discovery Software Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Computational Medicine and Drug Discovery Software Market Segment Percentages, by Type, 2022 (%)
Database
Software
Others
Global Computational Medicine and Drug Discovery Software Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Computational Medicine and Drug Discovery Software Market Segment Percentages, by Application, 2022 (%)
Computational Physiological Medicine
Drug Discovery And Development
Medical Imaging
Disease Modeling
Predictive Analysis Of Drug Targets
Cellular Simulation
Simulation Software
Global Computational Medicine and Drug Discovery Software Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Computational Medicine and Drug Discovery Software Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Computational Medicine and Drug Discovery Software revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Computational Medicine and Drug Discovery Software revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Entelos
Genedata
Crown Bioscience
Biognos
Chemical Computing Group
Leadscope
Nimbus Therapeutics
Rhenovia Pharma Limited
Schrodinger
Compugen
Dassault Systemes
Outline of Major Chapters:
Chapter 1: Introduces the definition of Computational Medicine and Drug Discovery Software, market overview.
Chapter 2: Global Computational Medicine and Drug Discovery Software market size in revenue.
Chapter 3: Detailed analysis of Computational Medicine and Drug Discovery Software company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Computational Medicine and Drug Discovery Software in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
